The World Health Organization signaled the emergence of antibiotic resistance, along with the steady decline in the discovery of new antibiotics, as a major health threat for the coming decade. To help control antibiotic resistance, better use of current agents is warranted and a decrease in inappropriate use of antibiotics is necessary [1] .
Antibiotic stewardship is an active interprofessional effort by multidisciplinary teams to optimize clinical outcome while minimizing unintended consequences of antibiotic use, including the emergence of resistance [2] . Literature shows that stewardship programs can decrease incorrect antibiotic use and reduce healthcare costs without negatively influencing the quality of care provided [2] . An important requirement for an effective stewardship program to set priorities and focus improvement is the ability to measure the appropriateness of hospital antibiotic use.
Guidelines on the management of infections describe, by definition, appropriate antibiotic use [3] . Adherence to such guidelines improves clinical outcome, is correlated with a lower rate of development of resistance to antibiotics, and lowers costs [4] [5] [6] [7] [8] . Available guidelines and international literature can be used to systematically develop precise parameters, so-called quality indicators (QIs), to measure the appropriateness of antibiotic use [9] [10] [11] . The European Surveillance of Antimicrobial Consumption developed QIs to measure appropriate outpatient antibiotic use in Europe [12] . However, at this moment generic antibiotic use indicators-that is, indicators for measuring the appropriateness of antibiotic use in the treatment of all bacterial infections in hospitalized patients-are not available, but they are increasingly requested by policy makers.
The aim of this study was to develop a set of generic indicators that can be used to assess the appropriateness of antibiotic use in the treatment of all bacterial infections in hospitalized adult patients.
METHODS
We applied the RAND modified Delphi method to develop a set of QIs for appropriate antibiotic use in the treatment of all bacterial infections in hospitalized adult patients, with the exception of patients treated in the intensive care unit (ICU) ( Figure 1 ) [13, 14] .
Literature Search
To create an inventory of already available QIs, we searched the databases of PubMed and Embase to identify studies regarding the development or evaluation of QIs for antibiotic use in hospitalized adults. The search strategies are listed in Figure 2A and 2B.
First, the abstracts were screened. Included were articles describing QIs for bacterial infections or antibiotic prescribing in hospitalized adult patients, excluding ICU Figure 1 . The RAND-modified Delphi procedure. Abbreviations: AB, antibiotic; QI, quality indicator.
patients. Potentially relevant publications were checked in fulltext format.
Next, from these included publications, potentially relevant indicators regarding antibiotic prescribing/use were extracted, after which the exclusion criteria were applied ( Figure 1 ). QIs were excluded if they did not concern antibiotic use, were specified for a specific group of patients, concerned antibiotic prophylaxis, or were not normative. This process of excluding QIs was done by 3 reviewers (C. v. d. B., S. E. G., and J. M. P.), who also determined the level of supporting evidence (Tables 1 and 2) .
First Questionnaire Round
The list of the potentially relevant QIs was converted into a written questionnaire and used for the RAND-modified Delphi method to achieve expert consensus on these QIs.
We invited 20 experts from different countries and different specialties. All but 3 of the invited experts consented to participate in this survey. Ultimately, our international expert panel was composed of 17 members from the Netherlands, Spain, Belgium, Scotland, Croatia, and Sweden, and consisted of 5 medical microbiologists, 4 infectious disease specialists, 2 clinical hospital pharmacists, 2 general surgeons, 2 pulmonologists, and 2 gynecologists (Supplementary Appendix 1).
We asked the experts ( panel members) to appraise the potential QIs while considering the following criteria:
• The recommended care leads to health gain for the patient or to less bacterial resistance, or promotes efficiency of care; Figure 2 . A, Search strategy in Medline. Limits: humans, English, French, German, Italian, Spanish, Dutch. B, Search strategy in Embase. Limits: not animals, English, French, German, Italian, Spanish, Dutch, not case reports. • The recommended care is generalizable to all adult patients treated with antibiotics for a bacterial infection;
• There is sufficient scientific evidence or expert consensus to justify the recommended care.
To rate the degree with which the potential QI described appropriate antibiotic use (in accordance with these criteria), a Likert scale was used ranging from 1 ("definitely not appropriate care") to 9 ("definitely appropriate care"), including an answer category "cannot assess." The panel members could rephrase the potential indicator and could add new items and/or QIs.
The results from the first questionnaire were analyzed using a standardized Microsoft Access-based consensus tool. QIs with a median score of 8 or 9 were accepted if there was no disagreement. Disagreement was defined as the case in which <70% of the scores were in the top tertile (scores 7, 8, or 9). If there was disagreement and the median score was ≤7, the QI was rejected. The QIs with a median score of 8 or 9 with disagreement or a median score of 7 without disagreement were discussed during the consensus meeting [15] .
Expert Panel Meeting
For pragmatic reasons, only Dutch panel members (n = 12) were invited for the expert panel meeting. The goal of the meeting was to present the results after the first round and to discuss the QIs with a median score of 8 or 9 with disagreement or a median score of 7 without disagreement. In addition, newly added potential QIs were discussed, and accepted QIs with comments from the experts were rephrased in consensus.
Second Questionnaire Round, Ranking Procedure
After the consensus meeting, all of the accepted, added, and rephrased potential QIs were presented again in a questionnaire for final remarks, approval of the panel members, and prioritization of the potential QIs by asking the panel members to select a personal "top 5" of most relevant QIs. An extensive summary with the results from the consensus meeting was sent to the panel members together with the second questionnaire.
Rephrased indicators were accepted if at least 70% of the experts agreed with the new formulation. When an indicator was mentioned first in a panelist's "top 5," it was granted 5 points; the second was given 4 points, the third indicator was granted 3 points, and so on. QIs receiving >15% of the maximum possible ranking points were considered to be the most important QIs for antibiotic care in all adult patients with a bacterial infection.
RESULTS

Literature Search
Of the 1574 identified articles regarding bacterial infections and/or antibiotic prescribing, 46 provided QIs, of which 29 articles described QIs for hospitalized adult patients, with the exception of patients treated in the ICU. From these 29 articles we derived 328 QIs, which also included 5 systematically developed, but at that moment not yet published QIs regarding antibiotic treatment in hospitalized adults with sepsis [16] (see Supplementary Appendix 2 for these 29 articles). With 3 reviewers, we applied the predefined exclusion criteria and 304 QIs were excluded, mostly because they did not concern antibiotic use (184 QIs) or were doubles (57 QIs) ( Figure 1 ). This resulted in 24 potential generic QIs. These 24 potential QIs were put into a written questionnaire and sent to the 17 panel members (Table 3 , numbers 1-24).
First Questionnaire Round
The consensus procedure was performed between May and October 2011. Sixteen members of the panel (all except 1 general surgeon) returned the first questionnaire (94% response). Eleven of the 24 initial indicators were accepted and 9 indicators were rejected ( Figure 1 and Table 3 ). The panel members disagreed on 4 potential QIs, and 10 new potential QIs were suggested (Table 3 , numbers 29, 33-41).
Expert Panel Meeting
Five (29%) Dutch panel members (1 medical microbiologist, 2 infectious disease specialists, 1 clinical hospital pharmacist, and 1 general surgeon) attended the consensus meeting. Discussed were the 11 accepted QIs with comments, the 4 with disagreement or a median score of 7, and the 10 newly proposed indicators from the first questionnaire round. Comments from the panel members regarding the first questionnaire were used to rephrase some of the accepted indicators. All 4 potential QIs requiring discussion and 9 of the 10 newly proposed QIs were rejected. From the 11 previously accepted indicators, 4 indicators were rephrased, 3 remained unchanged, and another 4 indicators were merged into 2 indicators with similar content (Table 3) . One additional potential QI was added during the meeting.
Second Questionnaire Round, Ranking Procedure
During the second questionnaire round, 11 potential QIs were presented to all panel members for final remarks and approval. All 17 questionnaires were returned (100% response) and no indicator was excluded, as ≥70% of the panelists agreed with each new formulation. The ranking of this entire set of indicators resulted in 6 QIs with the highest scores (Table 3) . Table 4 shows the entire set of 11 QIs representing the final, valid set of QIs that can be used to measure the appropriateness of antibiotic use in the treatment of all bacterial infections in hospitalized adult patients. b Discussion: the QI had a median score of 7 without disagreement or a median score of 8 or 9 with disagreement, and so it was discussed during the consensus meeting.
Final Set of Selected QIs
c Accepted: the potential QI was selected for the next round because of an overall median score of 8 or 9, without disagreement. Disagreement was defined as the case in which <70% of the scores were in the top tertile (score of 7, 8, or 9). d Merged: multiple indicators were "rejected" and merged into a composite, more generic indicator.
e Added: the indicator was proposed by one of the experts and was added to the initial set of indicators. Supporting evidence varied sometimes between populations (adults with pneumonia or with sepsis or with complicated UTI). 
DISCUSSION
To our knowledge, this is the first study that used the RAND modified Delphi method to systematically develop a concise set of generic QIs defining appropriate antibiotic use in the treatment of all bacterial infections in adult patients hospitalized at non-ICU departments. Antibiotic stewardship programs are increasingly being implemented in hospitals to optimize antibiotic use. Most important in these programs tends to be the provision of guidelines and instructions for prescribers, but this alone will not be sufficient to bring about change and improvement of antibiotic use [17] . Our set of generic QIs provides important parameters that can be used to measure the various steps in the process of antibiotic use on patient level-as described with our QIs-along the entire antibiotic pathway. These QIs enable stewardship teams to determine for which steps along the antibiotic pathway there is room for improvement, and to set priorities for targeted improvement actions in their specific hospital. The effectiveness of these actions can, again, be measured using the QIs. In this manner, a quality system can be introduced in hospitals to continuously self-monitor and improve the appropriateness of antibiotic use. Of course, our QIs can also be used by groups of hospitals for benchmarking inpatient hospital QI performance to further improve antibiotic use.
The generic set contains 11 QIs describing appropriate antibiotic use, from start to discontinuation of antibiotics. All indicators received a high score in the first questionnaire round. We also asked the panel members to rank this complete set, to see if there was a hierarchy within this set of QIs. The results shows that taking cultures, prescribing empirical therapy according to the guideline, and streamlining antibiotic therapy received the highest scores.
Our study has several strengths. First, the set of QIs was specifically designed for hospitalized patients. The European Surveillance of Antimicrobial Consumption developed QIs to measure appropriate outpatient antibiotic use in Europe [12, 18] . However, this set was not designed to measure the appropriateness of antibiotic use in individual patients. Second, we used the Delphi procedure, where scientific evidence is combined with expert opinion, which is well known and described in other studies [10, 11, 19] . The application of this systematic and rigorous consensus method for indicator development resulted in indicators with high content validity. Recently, 2 reviews were published on methods for developing QIs, and the use and reporting of the Delphi method. Both reviews reported a substantial variety among studies [20, 21] . Boulkedid and colleagues developed practical guidelines for using the RAND modified Delphi technique, and our procedure is consistent with these guidelines [20] .
Another strength was the multidisciplinary expert panel, which was an international panel in which all the main specialities involved in antibiotic treatment were represented. This resulted in a diversity of practices and opinions, which strengthens the results of the Delphi procedure. In addition, both the scientific literature search and the expert panel were international. We therefore believe these QIs represent a valid set that can be used internationally.
This study also has some limitations. Twenty-nine percent of the experts attended the panel meeting. All attendees were Dutch because of logistical reasons. Nevertheless, the response rates of the first and second questionnaire were 94% and 100%, respectively, which is very high. An extensive summary with regard to the results from the consensus meeting was sent to all panel members, and they were asked to give their final remarks and approval for the added and rephrased potential QIs. Because the entire panel returned the second questionnaire, we believe that an incomplete attendance did not undermine the validity of the results.
Another potential limitation was that none of the QIs had "grade 1" evidence (Tables 1-3 ). This is, however, exactly the reason we used the Delphi method, as it systematically combines evidence and consensus of experts, which enables the assessment of a broader range of topics than would otherwise be possible.
In conclusion, the applicability of QIs should always be tested in practice first, as registration of data is different in every country, which affects the feasibility, validity, and reliability of data collection [11] . Also, within a country, registration may vary between and sometimes even within clinical settings. We therefore strongly advise to first test the clinimetric properties of the QIs to discriminate between indicators that are feasible, valid, and reliable in a specific setting and those that are not. Such a test will also facilitate acceptance of the measures. For example, at this moment we are testing the clinimetric properties of our QIs in approximately 1800 hospitalized patients, in 22 Dutch hospitals. Similarly, the feasibility, validity, and reliability of the QIs should be tested in other countries/states, to check whether our antibiotic stewardship QIs are also applicable and comparable internationally.
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